| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-24397SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56457SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49891-0.1mg | |||
| BSA Free | NBP2-49891-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41296-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71793 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64347SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61727-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52716-0.025mg | |||
![Western Blot: SHIP2/INPPL1 [p Tyr497] Antibody [NBP2-24461] - Analysis of phosphorylated SHIP2 (Y497) in recombinant fusion protein containing 1) a phosphorylated tyrosine at position 497 and 2) an unphosphorylated tyrosine at position 497, using SHIP2 phospho antibody at 0.01 ug/ml.](http://images.novusbio.com/fullsize/SHIP2-INPPL1-[p-Tyr497]-Antibody-Western-Blot-NBP2-24461-img0004.jpg "Western Blot: SHIP2/INPPL1 [p Tyr497] Antibody [NBP2-24461] - Analysis of phosphorylated SHIP2 (Y497) in recombinant fusion protein containing 1) a phosphorylated tyrosine at position 497 and 2) an unphosphorylated tyrosine at position 497, using SHIP2 phospho antibody at 0.01 ug/ml.")
![Immunohistochemistry-Paraffin: SHIP2/INPPL1 [p Tyr497] Antibody [NBP2-24461] - Analysis of phosphorylated SHIP2 in formalin-fixed, paraffin-embedded human brain tissue using an isotype control (top) and this antibody (bottom) at 5 ug/ml.](http://images.novusbio.com/fullsize/SHIP2-INPPL1-[p-Tyr497]-Antibody-Immunohistochemistry-Paraffin-NBP2-24461-img0003.jpg)
![Immunohistochemistry-Paraffin: FoxP3 Antibody [NBP2-24397] - IHC analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using FOXP3 antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Nuclear staining was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/FoxP3-Antibody-Immunohistochemistry-Paraffin-NBP2-24397-img0002.jpg "Immunohistochemistry-Paraffin: FoxP3 Antibody [NBP2-24397] - IHC analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using FOXP3 antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Nuclear staining was observed. Staining was performed by Histowiz.")
![Western Blot: FoxP3 Antibody [NBP2-24397] - Analysis of FOXP3 in (A) FOXP3 transfected and (B) mock transfected cell lysate using NBP2-24397 at 5 ug/ml.](http://images.novusbio.com/fullsize/FoxP3-Antibody-Western-Blot-NBP2-24397-img0003.jpg)
![Western Blot: CD4 Antibody [NB100-56457] - Analysis of CD4 in human thymus lysate using this antibody at 2 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-Western-Blot-NB100-56457-img0002.jpg "Western Blot: CD4 Antibody [NB100-56457] - Analysis of CD4 in human thymus lysate using this antibody at 2 ug/ml.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0009.jpg "Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse IgG1 isotype control. Figure B: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse anti-Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0001.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: RPE conjugated Rat anti-Dog CD4 and Mouse IgG1 isotype control labeled with Goat anti-Mouse FITC. Figure B: RPE conjugated Rat anti-Dog CD4 and Mouse anti-Dog CD3 labeled with Goat anti Mouse DyLight FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0002.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0003.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG2a isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD4.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0004.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0005.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0006.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG1 isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD8.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and purified Rat IgG2a isotype control detected with Goat anti Rat IgG2a DyLight 649. Figure B. FITC conjugated Mouse anti Canine CD3 and purified Mouse anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0008.jpg)
![Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BATF3-Antibody-Western-Blot-NBP2-41296-img0002.jpg "Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.")
![Immunohistochemistry: BATF3 Antibody [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunohistochemistry-NBP2-41296-img0003.jpg)
![Immunofluorescence: BATF3 Antibody [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunofluorescence-NBP2-41296-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419313277.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202420285889.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419201566.gif)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419172279.gif)
![Western Blot: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Western-Blot-NBP2-45629-img0009.jpg "Western Blot: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.")
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0008.jpg)
![Flow Cytometry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells transfected with either RC200244 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by CLEC4E antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Flow-Cytometry-NBP2-45629-img0001.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0002.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0003.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0004.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0005.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0006.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0007.jpg)
![Immunohistochemistry: CD79A Antibody (HM57) [NB100-64347] - Paraffin-embedded alcohol fixed Rat Spleen tissue (20x). Antigen retrieval pH6. Dilution: 1:500 and ON incubation at 4C. This image was submitted via customer revies.](http://images.novusbio.com/fullsize/CD79A-Antibody-HM57-Immunohistochemistry-NB100-64347-img0005.jpg "Immunohistochemistry: CD79A Antibody (HM57) [NB100-64347] - Paraffin-embedded alcohol fixed Rat Spleen tissue (20x). Antigen retrieval pH6. Dilution: 1:500 and ON incubation at 4C. This image was submitted via customer revies.")
![Flow Cytometry: CD79A Antibody (HM57) [NB100-64347] - Using the Allophycocyanin direct conjugate An intracellular stain was performed on Daudi cells with CD79A (HM 57) antibody NB100-64347APC (blue) and a matched isotype control NBP1-97005APC (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 0.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Allophycocyanin.](http://images.novusbio.com/fullsize/CD79A-Antibody-HM57-Flow-Cytometry-NB100-64347-img0003.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (HM57) [NB100-64347] - Embedded human tonsil.](http://images.novusbio.com/fullsize/CD79A-Antibody-HM57-Immunohistochemistry-Paraffin-NB100-64347-img0002.jpg)
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0003.jpg "Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Analysis of anti-IL-17 antibody of mouse spleen at concentration 10 ug/ml.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - TG2-dependent chemokine production in keratinocytes is critical for IL-17-producing CCR6+ gamma δT-cell & neutrophil dermal infiltration.a, b Effect of DMSO- or IMQ-treated WT- or TG2−/−-CM on CCR6+ gamma δT-cell (a) & CD11b+ Ly-6G+ cell (b) migration according to Transwell migration assays. Flow cytometric analysis of the percentage of cells migrating toward the CM in the presence or absence of anti-CXCL1 (a) & anti-CCL20 (b) antibodies (n = 3/group). c, d WT & TG2−/− mouse-derived CCR6+ gamma δT-cell (c) & CD11b+ Ly-6G+ cell (d) migration in response to recombinant mouse CCL20 & CXCL1, respectively. Data represent the mean ± SEM (n = 3/group). *p < 0.05; **p < 0.01. e, f Cells were isolated from the back skin of WT & TG2−/− mice treated with IMQ for four consecutive days & analyzed by flow cytometry. Representative flow cytometric profiles of CCR6+ gamma δTCRlow cells (e) & CD11bhigh Ly-6G+ cells (f). The percentage of cells is shown. Data represent the mean ± SEM (n = 9/group). g Skin sections were immunostained with CCR6 (green)- & IL-17 (red)-specific antibodies. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. h–j Back skin was separated into epidermis & dermis & analyzed by RT-PCR for IL-17-producing gamma δT-cell markers (h) (Ccr6 & Il23r), IL17 & related cytokines (i) (Il17a, Il17f, & Il22), & myeloid cell-derived cytokines (j) (Il12a & Il23a). Data represent the mean ± SEM (n = 11/group). *p < 0.05; **p < 0.01 vs. WT mice. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32355189), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-72027_rat-il-17-il-17a-mab-tc11-18h10-azide-and-bsa-free-310202416171471.jpg)
![Immunocytochemistry/Immunofluorescence: CD2 Antibody (OX-34) [NB100-65228] - (A, B, C) Egg chambers at S6 stained with antibodies against SMRTER and Hindsight (Hnt) (A), CD2 (B), or Cut (C). (D) An egg chamber at S4 stained with antibodies against SMRTER and Cut. (E, F) Egg chambers at S8/S9 stained with antibodies against SMRTER and CD2 (E) or Hnt (F). (G) An egg chamber at S10A stained with antibodies against SMRTER and Hnt.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Immunofluorescence-NB100-65228-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD2 Antibody (OX-34) [NB100-65228] - (A, B, C) Egg chambers at S6 stained with antibodies against SMRTER and Hindsight (Hnt) (A), CD2 (B), or Cut (C). (D) An egg chamber at S4 stained with antibodies against SMRTER and Cut. (E, F) Egg chambers at S8/S9 stained with antibodies against SMRTER and CD2 (E) or Hnt (F). (G) An egg chamber at S10A stained with antibodies against SMRTER and Hnt.")
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. RPE conjugated Mouse anti Rat CD2 and FITC conjugated Mouse IgM isotype control. Figure B. RPE conjugated Mouse anti Rat CD2 and FITC conjugated Mouse anti Rat CD3.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0003.jpg)
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse IgG2a isotype control. Figure B. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse anti Rat CD2.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0001.jpg)
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse IgG2a isotype control. Figure B. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse anti Rat CD2.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0002.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against HEK293 (1) and CD2 (AA: 25-140)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0006.jpg "Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against HEK293 (1) and CD2 (AA: 25-140)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of endometrial cancer tissues using CD2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Immunohistochemistry-NBP2-61727-img0004.jpg)
![Flow Cytometry: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of HepG2 cells using CD2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Flow-Cytometry-NBP2-61727-img0008.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against human CD2 (AA: 25-140) recombinant protein. Expected MW is 39.2 kDa.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0005.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mouse mAb against MOLT4 (1), MCF-7 (2), L1210 (3), U937 (4), and NIH3T3 (5) cell lysate.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0007.jpg)
![Immunohistochemistry-Paraffin: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of rectum cancer tissues using CD2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Immunohistochemistry-NBP2-61727-img0003.jpg)
![Flow Cytometry: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of HeLa cells using CD2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Flow-Cytometry-NBP2-61727-img0002.jpg)
![ELISA: CD2 Antibody (3D1E3) [NBP2-61727] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-ELISA-NBP2-61727-img0001.jpg)
![Western Blot: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Western-Blot-NBP2-71793-img0001.jpg "Western Blot: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.")
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0008.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0003.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0004.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0005.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0006.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0007.jpg)
![Immunohistochemistry: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71793-img0009.jpg)
![CyTOF-ready: CLEC4E Antibody (OTI2A8) - Azide and BSA Free [NBP2-71793] - Analysis of HEK293T cells transfected with either RC200244 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostaining by CLEC4E antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-OTI2A8-Azide-and-BSA-Free-CyTOF-ready-NBP2-71793-img0002.jpg)